NEW YORK, July 10 - Amersham Biosciences and GeneticXchange have co-developed a platform to help researchers integrate lab-generated data with legacy, public, third party, and clinical data, the firms said today.

The platform brings together Amersham's Scierra Laboratory Workflow System with GeneticXchange's discoveryHub data-integration platform. It will be available during the current quarter, and Amersham will sell it worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.